Mizuho Maintains Buy on Omega Healthcare Invts, Lowers Price Target to $34
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Haendel St. Juste has maintained a Buy rating on Omega Healthcare Investors (NYSE:OHI) but has reduced the price target from $35 to $34.

January 03, 2024 | 3:37 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Mizuho has maintained a Buy rating on Omega Healthcare Investors but lowered the price target from $35 to $34.
While the reduction in price target could suggest a slightly less optimistic outlook, the maintenance of a Buy rating indicates that the overall positive sentiment towards OHI remains unchanged. The impact on the stock price is likely to be neutral in the short term as the price target adjustment is minor.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100